Cargando…

1(st) World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23–26, 2011, Zentralklinik Bad Berka, Germany

Detalles Bibliográficos
Autores principales:	Baum, Richard P., Rösch, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198045/ https://www.ncbi.nlm.nih.gov/pubmed/22034575 http://dx.doi.org/10.4103/1450-1147.82105

Ejemplares similares

1(st) World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT)
por: Padhy, Ajit Kumar
Publicado: (2011)

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
por: Baum, Richard P., et al.
Publicado: (2012)

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
por: Zaknun, John J., et al.
Publicado: (2013)

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
por: Bodei, L., et al.
Publicado: (2013)

Abstracts of Poster Presentations (PRRNT)
Publicado: (2011)

Instant kit preparation of (68)Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [(68)Ga]Ga-DATA-TOC
por: Sinnes, Jean-Philippe, et al.
Publicado: (2019)

Preparation and Surface Characterization of Cerium Dioxide for Separation of (68)Ge/(68)Ga and Other Medicinal Radionuclides
por: Ondrák Fialová, Kateřina, et al.
Publicado: (2023)

Prospective of (68)Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation
por: Velikyan, Irina
Publicado: (2018)

EPMA-World Congress 2011 in Bonn, Germany
Publicado: (2011)

Characterization of SnO(2)-based (68)Ge/(68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy
por: Sudbrock, Ferdinand, et al.
Publicado: (2014)

Thirteenth World Congress on Menopause, Rome, 8 – 11 June, 2011
por: Singh, Meeta, et al.
Publicado: (2011)

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [(68)Ga]Ga-DATA(5m).SA.FAPi
por: Greifenstein, Lukas, et al.
Publicado: (2022)

Cyclotron-based production of (68)Ga, [(68)Ga]GaCl(3), and [(68)Ga]Ga-PSMA-11 from a liquid target
por: Rodnick, Melissa E., et al.
Publicado: (2020)

The Dependence of Renal (68)Ga[Ga]-DOTATOC Uptake on Kidney Function and Its Relevance for Peptide Receptor Radionuclide Therapy with (177)Lu[Lu]-DOTATOC
por: Gühne, Falk, et al.
Publicado: (2021)

Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT
por: Oh, Sowon, et al.
Publicado: (2011)

Meningiomas: A Comparative Study of (68)Ga-DOTATOC, (68)Ga-DOTANOC and (68)Ga-DOTATATE for Molecular Imaging in Mice
por: Soto-Montenegro, María Luisa, et al.
Publicado: (2014)

(68)Ga‐Labelled Tropane Analogues for the Visualization of the Dopaminergic System
por: Häseli, Sascha, et al.
Publicado: (2020)

Automated GMP Production and Preclinical Evaluation of [(68)Ga]Ga-TEoS-DAZA and [(68)Ga]Ga-TMoS-DAZA
por: Greiser, Julia, et al.
Publicado: (2022)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

Diagnosis of Men-I Syndrome on (68)Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE
por: kumar Gupta, Santosh, et al.
Publicado: (2012)

Comparison of [(18)F]DOPA and [(68)Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
por: Veenstra, Emile B., et al.
Publicado: (2022)

34-June 2011
Publicado: (2011)

In the June 2011 issue
por: Nitrini, Ricardo
Publicado: (2011)

AAZTA(5)/AAZTA(5)-TOC: synthesis and radiochemical evaluation with (68)Ga, (44)Sc and (177)Lu
por: Sinnes, Jean-Philippe, et al.
Publicado: (2019)

EPMA-World Congress 2011
Publicado: (2011)

[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021)

Run 68, 9th June 1971
por: Fischer, E, et al.
Publicado: (1971)

Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013)

The (68)Ge/(68)Ga generator has high potential, but when can we use (68)Ga-labelled tracers in clinical routine?
por: Breeman, Wouter A. P., et al.
Publicado: (2007)

Artificial intelligence-based (68)Ga-DOTATOC PET denoising for optimizing (68)Ge/(68)Ga generator use throughout its lifetime
por: Quak, Elske, et al.
Publicado: (2023)

Initial Clinical Experience with (68)Ga-DOTA-NOC Prepared Using (68)Ga from Nanoceria-polyacrylonitrile Composite Sorbent-based (68)Ge/(68)Ga Generator and Freeze-dried DOTA-NOC Kits
por: Chandra, Piyush, et al.
Publicado: (2017)

Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE
por: Schottelius, Margret, et al.
Publicado: (2015)

Germany and the Pan-American Medical Congress
Publicado: (1893)

Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [(68)Ge]Ge/[(68)Ga]Ga Generators: Fractional Elution or Prepurification?
por: Durieux, Flore, et al.
Publicado: (2023)

Image quality analysis of (44)Sc on two preclinical PET scanners: a comparison to (68)Ga
por: Rosar, Florian, et al.
Publicado: (2020)

(68)Ga-Triacetylfusarinine C and (68)Ga-Ferrioxamine E for Aspergillus Infection Imaging: Uptake Specificity in Various Microorganisms
por: Petrik, Milos, et al.
Publicado: (2013)

Fully Automated Production of [(68)Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2023)

Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)

A prospective head-to-head comparison of [(68)Ga]Ga-P16-093 and [(68)Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
por: Wang, Guochang, et al.
Publicado: (2023)

[(68)Ga]Ga-PSMA and [(68)Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration
por: Ghezzo, Samuele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0gg225u0op7ec5krkcdsmu5vbc